|
1999 Book Chapter Safety and Immunogenicity of HPV16 E7/AlgammulinFrazer, I. H., Tindle, R. W., Fernando, G. J., Malcolm, K. M., Herd, K. A., McFadyen, S. M., Cooper, P. D. and Ward, B. G. (1999). Safety and Immunogenicity of HPV16 E7/Algammulin. Vaccines for Human Papillomavirus Infection and Anogenital Disease. (pp. 91-104) edited by R. W. Tindle. Austin, USA: R.G. Landes Company. |
|
1999 Book Chapter Cell mediated immunity to papillomavirusesFrazer, I. H. and Tindle, R. (1999). Cell mediated immunity to papillomaviruses. Current research on papillomaviruses. (pp. 151-164) edited by Charles Lacey. Leeds, England: Leeds University Press. |
|
1999 Book Chapter Immunomodulation of HPV infection and diseaseTindle, R. W. (1999). Immunomodulation of HPV infection and disease. Vaccines for Human Papillomavirus Infection and Anogenital Disease. (pp. 1-12) edited by Robert W. Tindle. Texas, USA: R. G. Landes Company. |
|
1986 Book Chapter Reactivity of a Monoclonal Antibody Defining Human Hematopoietic Multipotential ProgenitorsKatz, Fay E., Tindle, Robert W., Sutherland, Robert and Greaves, Melvyn F. (1986). Reactivity of a Monoclonal Antibody Defining Human Hematopoietic Multipotential Progenitors. Leukocyte Typing II. (pp. 305-314) New York, NY: Springer New York. doi: 10.1007/978-1-4612-4850-7_26 |
|
1985 Book Chapter Monoclonal antibody BI-3C5 reacts Ssecifically with M1/M2-Acute myeloid leukaemias and most Non-B Non-T acute lymphocytic leukaemias, and recognises a small population of immature cells in normal bone marrowTINDLE, R.W., NICHOLS, R.A.B., CATOVSKY, D., CAMPANA, D. and CHAN, L.C. (1985). Monoclonal antibody BI-3C5 reacts Ssecifically with M1/M2-Acute myeloid leukaemias and most Non-B Non-T acute lymphocytic leukaemias, and recognises a small population of immature cells in normal bone marrow. Protides of the Biological Fluids. (pp. 897-900) Oxford: Elsevier. doi: 10.1016/b978-0-08-031739-7.50221-4 |
